Submission date
19/07/2004
Registration date
20/07/2004
Last edited
10/08/2007
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Pregnancy and Childbirth
Retrospectively registered
? Protocol not yet added
? SAP not yet added
Results added
? Raw data not yet added
Study completed

Plain English Summary

Not provided at time of registration

Study website

Contact information

Type

Scientific

Contact name

Prof G Justus Hofmeyr

ORCID ID

Contact details

P Bag X9047
East London
5201
South Africa
+27 (0)832809402
gjh@global.co.za

Additional identifiers

EudraCT/CTIS number

IRAS number

ClinicalTrials.gov number

Protocol/serial number

CRHS010215a

Study information

Scientific title

Acronym

Study hypothesis

Not provided at time of registration

Ethics approval(s)

Not provided at time of registration

Study design

Randomised controlled trial

Primary study design

Interventional

Secondary study design

Randomised controlled trial

Study setting(s)

Not specified

Study type

Screening

Patient information sheet

Condition

Postpartum haemorrhage

Intervention

1. Intervention group: Misoprostol 200 µg tablets. Each woman receives 1 tablet orally, 2 tablets sublingually and 2 tablets rectally.
2. Control group: identical placebo tablets. Each woman receives 1 tablet orally, 2 tablets sublingually and 2 tablets rectally.
(All women receive routine accepted treatment for postpartum haemorrhage)

Intervention type

Drug

Pharmaceutical study type(s)

Phase

Not Specified

Drug/device/biological/vaccine name(s)

Misoprostol

Primary outcome measure

Not provided at time of registration

Secondary outcome measures

Not provided at time of registration

Overall study start date

01/01/2002

Overall study end date

01/12/2003

Reason abandoned (if study stopped)

Eligibility

Participant inclusion criteria

Women with postpartum haemorrhage defined as vaginal bleeding after childbirth considered to be excessive, and considered likely to be due to inadequate uterine contraction

Participant type(s)

Patient

Age group

Adult

Sex

Female

Target number of participants

Not provided at time of registration

Participant exclusion criteria

Not provided at time of registration

Recruitment start date

01/01/2002

Recruitment end date

01/12/2003

Locations

Countries of recruitment

South Africa

Study participating centre

P Bag X9047
East London
5201
South Africa

Sponsor information

Organisation

University of the Witwatersrand (South Africa)

Sponsor details

7
York Rd
Parktown
Johannesburg
2193
South Africa
+27 (0)11 717 2000
gjh@global.co.za

Sponsor type

University/education

Website

ROR

https://ror.org/03rp50x72

Funders

Funder type

University/education

Funder name

University of the Witwatersrand (South Africa) - No external funding; this trial was funded from the existing research unit budget, using full-time research staff.

Alternative name(s)

Funding Body Type

Funding Body Subtype

Location

Results and Publications

Publication and dissemination plan

Not provided at time of registration

Intention to publish date

Individual participant data (IPD) sharing plan

IPD sharing plan summary

Not provided at time of registration

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article Results 06/08/2004 Yes No

Additional files

Editorial Notes